Dr Adrian Minson (BA LLB MBBS PhD FRACP FRCPA) is a haematologist and clinician researcher with a special interest in novel immunotherapies for aggressive B-cell lymphomas. He completed a lymphoma fellowship and PhD at the Peter MacCallum Cancer Centre and Royal Melbourne Hospitals investigating how to best use T-cell re-directing immunotherapies to improve patient outcomes. This included the first investigator-initiated study testing the combination of CAR T-cells and bruton tyrosine kinase inhibitors in mantle cell lymphoma. Adrian is an investigator on numerous early-phase studies using CAR T-cells and bispecific antibodies, and is an active member of the ALLG, participating in running a program of Australia- and NZ-wide investigator-initiated studies using these treatments in key high-risk patient populations.